Heuking advises Exasol AG on capital increase

A team led by Heuking Partner Dr. Thorsten Kuthe, Cologne, legally advised and supported Exasol AG on a capital increase. Exasol AG (ISIN DE000A0LR9G9) successfully placed 2,443,887 new shares with institutional and qualified investors. The issue was carried out as part of a private placement by way of an accelerated bookbuilding process excluding subscription rights and by partially utilizing authorized capital. The new shares were placed at a price of EUR 2.90 per share, resulting in gross proceeds of about EUR 7.1 million.

Net proceeds from the capital increase are primarily intended to improve the company’s equity base. The funds are also designed to support the company’s long-term growth strategy. Due to high demand, bookbuilding was completed shortly after the launch. Several members of the Executive Board and the Supervisory Board also acquired shares as part of the capital increase.

Hauck Aufhäuser and M.M.Warburg & CO acted as Joint Global Coordinators for the capital increase.

Counsel to Exasol AG
Heuking Kühn Lüer Wojtek:

Dr. Thorsten Kuthe, (Lead)
Miriam Schäfer,
Tatiana Vorotnitskaya, k.i.n. (all Capital Markets), all Cologne

Download as PDF

Contact persons

You are currently using an outdated and no longer supported browser (Internet Explorer). To ensure the best user experience and save you from possible problems, we recommend that you use a more modern browser.